These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 22891999)

  • 21. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study.
    Mastbergen SC; Jansen NW; Bijlsma JW; Lafeber FP
    Arthritis Res Ther; 2006; 8(1):R2. PubMed ID: 16356188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis.
    Marcouiller P; Pelletier JP; Guévremont M; Martel-Pelletier J; Ranger P; Laufer S; Reboul P
    J Rheumatol; 2005 Apr; 32(4):704-12. PubMed ID: 15801029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine receptor-like factor 1 is highly expressed in damaged human knee osteoarthritic cartilage and involved in osteoarthritis downstream of TGF-beta.
    Tsuritani K; Takeda J; Sakagami J; Ishii A; Eriksson T; Hara T; Ishibashi H; Koshihara Y; Yamada K; Yoneda Y
    Calcif Tissue Int; 2010 Jan; 86(1):47-57. PubMed ID: 19921088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB.
    Singh R; Ahmed S; Islam N; Goldberg VM; Haqqi TM
    Arthritis Rheum; 2002 Aug; 46(8):2079-86. PubMed ID: 12209512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
    Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
    Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9.
    Cucchiarini M; Thurn T; Weimer A; Kohn D; Terwilliger EF; Madry H
    Arthritis Rheum; 2007 Jan; 56(1):158-67. PubMed ID: 17195218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes.
    Kim HA; Cho ML; Choi HY; Yoon CS; Jhun JY; Oh HJ; Kim HY
    Arthritis Rheum; 2006 Jul; 54(7):2152-63. PubMed ID: 16802353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes.
    Nah SS; Choi IY; Lee CK; Oh JS; Kim YG; Moon HB; Yoo B
    Rheumatology (Oxford); 2008 Apr; 47(4):425-31. PubMed ID: 18285354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13.
    Jones SW; Watkins G; Le Good N; Roberts S; Murphy CL; Brockbank SM; Needham MR; Read SJ; Newham P
    Osteoarthritis Cartilage; 2009 Apr; 17(4):464-72. PubMed ID: 19008124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment.
    de Boer TN; Huisman AM; Polak AA; Niehoff AG; van Rinsum AC; Saris D; Bijlsma JW; Lafeber FJ; Mastbergen SC
    Osteoarthritis Cartilage; 2009 Apr; 17(4):482-8. PubMed ID: 18926729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetraspanin CD151 is expressed in osteoarthritic cartilage and is involved in pericellular activation of pro-matrix metalloproteinase 7 in osteoarthritic chondrocytes.
    Fujita Y; Shiomi T; Yanagimoto S; Matsumoto H; Toyama Y; Okada Y
    Arthritis Rheum; 2006 Oct; 54(10):3233-43. PubMed ID: 17009258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.
    LeGrand A; Fermor B; Fink C; Pisetsky DS; Weinberg JB; Vail TP; Guilak F
    Arthritis Rheum; 2001 Sep; 44(9):2078-83. PubMed ID: 11592370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
    Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
    J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yin-Yang regulation of prostaglandins and nitric oxide by PGD2 in human arthritis: reversal by celecoxib.
    Dave M; Amin AR
    Immunol Lett; 2013 Apr; 152(1):47-54. PubMed ID: 23603366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes.
    Henrotin YE; Deberg MA; Crielaard JM; Piccardi N; Msika P; Sanchez C
    J Rheumatol; 2006 Aug; 33(8):1668-78. PubMed ID: 16832844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
    Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
    Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage.
    Aigner T; Hemmel M; Neureiter D; Gebhard PM; Zeiler G; Kirchner T; McKenna L
    Arthritis Rheum; 2001 Jun; 44(6):1304-12. PubMed ID: 11407689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsp90{beta} and p130(cas): novel regulatory factors of MMP-13 expression in human osteoarthritic chondrocytes.
    Fan Z; Tardif G; Hum D; Duval N; Pelletier JP; Martel-Pelletier J
    Ann Rheum Dis; 2009 Jun; 68(6):976-82. PubMed ID: 18593760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of S100A12 in the pathogenesis of osteoarthritis.
    Nakashima M; Sakai T; Hiraiwa H; Hamada T; Omachi T; Ono Y; Inukai N; Ishizuka S; Matsukawa T; Oda T; Takamatsu A; Yamashita S; Ishiguro N
    Biochem Biophys Res Commun; 2012 Jun; 422(3):508-14. PubMed ID: 22609404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of cyclooxygenase-2 expression in bovine chondrocytes in culture by interleukin 1alpha, tumor necrosis factor-alpha, glucocorticoids, and 17beta-estradiol.
    Morisset S; Patry C; Lora M; de Brum-Fernandes AJ
    J Rheumatol; 1998 Jun; 25(6):1146-53. PubMed ID: 9632078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.